Symposia: Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, adult, Acute Myeloid Malignancies, AML, Biological therapies, Lymphoid Leukemias, ALL, clinical trials, Non-Biological therapies, Translational Research, Combination therapy, Clinical Research, pediatric, GVHD, Diseases, Immune Disorders, Therapies, Lymphoid Malignancies, Myeloid Malignancies, Study Population, Human, Transplantation
Type: Oral
Hematology Disease Topics & Pathways:
Research, adult, Acute Myeloid Malignancies, AML, Biological therapies, Lymphoid Leukemias, ALL, clinical trials, Non-Biological therapies, Translational Research, Combination therapy, Clinical Research, pediatric, GVHD, Diseases, Immune Disorders, Therapies, Lymphoid Malignancies, Myeloid Malignancies, Study Population, Human, Transplantation
Monday, December 12, 2022: 10:30 AM-12:00 PM
252-254
(Ernest N. Morial Convention Center)
Moderators:
Dražen Pulanić, MD, PhD, University Hospital Centre Zagreb
and
Betty K. Hamilton, MD, Cleveland Clinic Foundation
Disclosures:
Hamilton: Equilium: Membership on an entity's Board of Directors or advisory committees; Syndax: Membership on an entity's Board of Directors or advisory committees; Nkarta: Membership on an entity's Board of Directors or advisory committees; Incyte: Membership on an entity's Board of Directors or advisory committees; Kadmon: Membership on an entity's Board of Directors or advisory committees; Mallinkrodt: Speakers Bureau.
This session will focus on novel agents in the treatment of acute and chronic GVHD.
10:30 AM
11:00 AM
11:15 AM
11:30 AM
11:45 AM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH